台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    85.7
  • 漲跌
    ▲0.9
  • 漲幅
    +1.06%
  • 成交量
    82
  • 產業
    上市 生技醫療類股
  • 353人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
旭富 (4119)籌碼相關-華南永昌-內壢 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

華南永昌-內壢 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/160.183.9000.0084.000.12710.04%
2025/01/15083.8000.0084.1002700.00%
2025/01/090.289.4000.0088.500.22510.08%
2024/12/160.190.3000.0090.300.12420.04%
2024/12/120.193.3000.0092.500.12330.04%
2024/12/090.194.3000.0093.400.12240.04%
2024/12/050.197.6000.0097.400.12180.05%
2024/12/0300.00198.4097.80-1216-0.46%
2024/12/023.196.64196.1096.102.12041.03%
2024/11/22198.00197.5097.5001810.00%
2024/11/2100.00097.0098.0001780.00%
2024/11/20097.9000.0097.8001720.00%
2024/11/15195.0000.0095.5011470.68%
2024/11/12194.2000.0094.3011230.81%
2024/10/0700.00392.0092.20-3135-2.21%
2024/09/0500.00187.8086.50-1160-0.62%
2024/09/04287.1000.0087.0021651.21%
2024/08/2100.00389.1089.40-3180-1.66%
2024/08/1400.000.389.3089.30-0.3191-0.14%
2024/08/0900.00090.6091.0002040.00%
2024/08/05286.50187.0086.6012140.47%
2024/05/2200.000.192.2092.40-0.1235-0.04%
2024/05/17193.8000.0093.9012300.43%
2024/05/1300.00091.8091.8002320.00%
2024/05/10091.001.190.3490.90-1.1240-0.46%
2024/05/0900.000.188.7088.50-0.1243-0.04%
2024/05/0300.00388.5788.50-3242-1.24%
2024/04/2500.00388.7088.50-3245-1.22%
2024/04/19387.0000.0086.4032541.18%
2024/04/03187.8000.0087.8012580.39%
2024/03/28188.40388.8088.30-2258-0.78%
2024/03/27188.20088.4087.5012590.37%
2024/03/25088.000.487.9087.60-0.4261-0.13%
2024/03/22387.2000.0087.6032651.13%
2024/03/1900.00388.2387.90-3280-1.07%
2024/03/18186.9000.0086.9012840.35%
2024/03/14387.1000.0087.2032861.05%
2024/03/13387.7000.0087.9032851.05%
2024/03/0700.00390.6790.50-3269-1.11%
2024/03/06190.8000.0090.9012700.37%
2024/02/2300.00091.3091.1002830.00%
2024/02/22091.7000.0091.3002830.00%
2024/02/21291.1000.0091.2022830.70%
2024/02/16090.60490.3090.60-4285-1.39%
2024/02/02191.20290.9090.80-1290-0.34%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章